Fig. 2From: Clusterin modulates transdifferentiation of non-small-cell lung cancerScatter diagram shows that the level of clusterin in serum is a potential biomarker in lung cancer. The level of clusterin in the serum was detected in lung cancer patients and normal control. The results show that the level of clusterin is higher in lung cancer patient (a) and it could be a potential biomarker (b)Back to article page